Kerbside

The recommendations provided in this column are taken from various market sources such as brokers, analysts, dealers and investment strategists, etc. These recommendations may not be backed by strong fundamentals. Therefore we advise readers to use their own discretion before investing in these recommendation

AMBITIOUS TARGETS [EasyDNNnews:PaidContentStart]

Dishman Carbogen Amcis
BSE Code: 540701
CMP: ₹237.85 

Dishman Carbogen Amcis Ltd is engaged in Contract Research and Manufacturing Services (CRAMS) and the manufacture and supply of marketable molecules. In Q2 FY25, the company's revenue reached ₹789 crore, marking the highest revenue in a single quarter. It witnessed a turnaround by reporting PAT of ₹33 crore, resulting in a PAT margin of about 4.2 per cent. The company targets CHF 255 million for FY25. The manufacturing facility at Bavla aims to earn revenue at ₹300 crore this year, with 25-30 per cent growth next year. EBITDA margin guidance is 16-17 per cent for this year. With CAPEX of USD 15.9 million for H1 FY25, profitability turnaround, and ambitious targets for FY25, the company has potential and it could emerge as a dark horse in its sector. 

ON A GROWTH TRAJECTORY 

Solara Active Pharma Sciences
BSE Code: 541540
CMP: ₹817.65 

The demerged API business of Strides Shasun, listed as Solara Active Pharma Sciences Ltd, is engaged in the business of manufacturing, production, processing, formulating, sale, import, export, merchandising, distributing, and trading APIs. The company saw a turnaround last September quarter and expects further OPEX savings of ₹10-12 crore in the next two quarters. The management plans growth via the Vizag facility and focuses on margin expansion for the upcoming quarters. The polymers division is fully sold out, and the Vizag plant is retrofitting for capacity expansion making it a worthy buy. 

BRIMMING WITH POSITIVE SENTIMENTS 

XPRO India
BSE Code: 590013
CMP: ₹1,216.35 

XPRO India Ltd is a diversified multi-divisional company in the polymer processing industry. It is a leading manufacturer of coextruded plastic films, thermoformed liners, and speciality films in India. In the Q2FY25, the company reported revenue of ₹133.98 crore, with a year-on-year growth of 21.83 per cent. The company has already surpassed its revenue for FY24 in just nine months as the net profit stood at `9.94 crore, reflecting a year-on-year growth of 4.85 per cent. There was a mix of positives and negatives for the company last quarter. The stock price is trading near a 52-week high, suggesting positive sentiments. 

GREAT DEMAND OUTLOOK 

Apollo Tyres
BSE Code: 500877
CMP: ₹519.50 

Apollo Tyres Ltd manufactures automatic bias and radial tyres, and tubes. The product portfolio includes leading tyre brands for T&B, light trucks, passenger cars, and farm vehicles in India, serving OEMs and the replacement market. There is an anticipation of improved demand momentum in H2 FY25, in the replacement segment, with a projected double-digit growth for the full year. Management remains cautiously optimistic about future performance, with expectations for margin improvement as raw material costs stabilise and replacement demand strengthens. The company saw an increase in net debt this quarter driven by an increase in short-term borrowings, however, long-term debt decreased. Its outlook remains positive, supported by anticipated growth and margin improvement. 

(Closing price as of November 26, 2024) 

[EasyDNNnews:PaidContentEnd] [EasyDNNnews:UnPaidContentStart]

[EasyDNNnews:UnPaidContentEnd]